Elizabeth Jinks

503 total citations
8 papers, 203 citations indexed

About

Elizabeth Jinks is a scholar working on Immunology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Elizabeth Jinks has authored 8 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Biomedical Engineering and 2 papers in Molecular Biology. Recurrent topics in Elizabeth Jinks's work include Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Nanowire Synthesis and Applications (2 papers). Elizabeth Jinks is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Nanowire Synthesis and Applications (2 papers). Elizabeth Jinks collaborates with scholars based in United Kingdom, Switzerland and Italy. Elizabeth Jinks's co-authors include Steven P. Lee, Joseph Robinson, Baksho Kaul, Abeer M. Shaaban, Zsuzsanna Nagy, Roy Bicknell, Deirdre Kelly, Alfie T. Baker, Biju Parekkadan and Muath Suliman and has published in prestigious journals such as Nature Immunology, PLoS ONE and PLoS Biology.

In The Last Decade

Elizabeth Jinks

8 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Jinks United Kingdom 6 109 91 74 29 21 8 203
Angelina De Martin Switzerland 9 162 1.5× 66 0.7× 78 1.1× 22 0.8× 12 0.6× 13 261
Verena van der Heide United States 9 138 1.3× 69 0.8× 90 1.2× 41 1.4× 13 0.6× 18 292
Wilson Wei Sheng Tan Singapore 8 134 1.2× 91 1.0× 59 0.8× 15 0.5× 18 0.9× 10 217
Amirhosein Maali Iran 7 48 0.4× 85 0.9× 98 1.3× 14 0.5× 21 1.0× 26 219
Katka Franke Netherlands 7 175 1.6× 57 0.6× 70 0.9× 7 0.2× 14 0.7× 9 233
Ayako Demachi‐Okamura Japan 9 168 1.5× 150 1.6× 48 0.6× 10 0.3× 15 0.7× 19 257
Mika Yagoto Japan 8 128 1.2× 87 1.0× 83 1.1× 10 0.3× 10 0.5× 12 231
Soraya Zorro Manrique United States 4 144 1.3× 112 1.2× 50 0.7× 8 0.3× 41 2.0× 4 230
Jim Middelburg Netherlands 8 143 1.3× 179 2.0× 70 0.9× 8 0.3× 27 1.3× 13 308
Jenna L. Collier United States 4 204 1.9× 150 1.6× 67 0.9× 10 0.3× 18 0.9× 6 305

Countries citing papers authored by Elizabeth Jinks

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Jinks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Jinks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Jinks more than expected).

Fields of papers citing papers by Elizabeth Jinks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Jinks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Jinks. The network helps show where Elizabeth Jinks may publish in the future.

Co-authorship network of co-authors of Elizabeth Jinks

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Jinks. A scholar is included among the top collaborators of Elizabeth Jinks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Jinks. Elizabeth Jinks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sheriff, Lozan, et al.. (2024). Lag3 and PD-1 pathways preferentially regulate NFAT-dependent TCR signalling programmes during early CD4+ T cell activation. PubMed. 5(1). ltaf015–ltaf015. 1 indexed citations
2.
Copland, Alastair, Elizabeth Jinks, Nancy Gudgeon, et al.. (2024). Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. EMBO Molecular Medicine. 16(12). 3057–3088. 6 indexed citations
3.
Harrison, Neale, Zhi Li, Fabiana Corsi‐Zuelli, et al.. (2023). Regulation of pro‐inflammatory cytokine release by purinergic signalling in a human monocyte‐derived microglial model. Alzheimer s & Dementia. 19(S24). 1 indexed citations
4.
Jinks, Elizabeth, Tracey A. Haigh, Baksho Kaul, et al.. (2022). Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition. Nature Immunology. 23(12). 1726–1734. 19 indexed citations
5.
Zhuang, Xiaodong, Federica Maione, Joseph Robinson, et al.. (2020). CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. JCI Insight. 5(19). 58 indexed citations
6.
Robinson, Joseph, et al.. (2020). An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours. The Journal of Pathology Clinical Research. 6(4). 308–319. 12 indexed citations
7.
Robinson, Joseph, et al.. (2019). TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo. PLoS ONE. 14(10). e0224015–e0224015. 34 indexed citations
8.
Knoblich, Konstantin, Sara Cruz Migoni, Susan Siew, et al.. (2018). The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation. PLoS Biology. 16(9). e2005046–e2005046. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026